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Background: Prior studies have demonstrated that U.S. Hispanic smokers have a lower risk of decline in lung 
function and chronic obstructive pulmonary disease (COPD) compared with non-Hispanic whites (NHW). This 
suggests there might be racial-ethnic differences in susceptibility in cigarette smoke-induced respiratory 
symptoms, lung parenchymal destruction, and airway and vascular disease, as well as in extra-pulmonary 
manifestations of COPD. Therefore, we aimed to explore respiratory symptoms, lung function, and pulmonary and 
extra-pulmonary structural changes in Hispanic and NHW smokers.
Methods: We compared respiratory symptoms, lung function, and computed tomography (CT) measures of 
emphysema-like tissue, airway disease, the branching generation number (BGN) to reach a 2-mm-lumen-diameter 
airway, and vascular pruning as well as muscle and fat mass between 39 Hispanic and 39 sex-, age- and smoking 
exposure-matched NHW smokers. 
Results: Hispanic smokers had higher odds of dyspnea than NHW after adjustment for COPD and asthma statuses 
(odds ratio[OR]=2.96; 95% confidence interval [CI] 1.09-8.04), but no significant differences were found in lung 
function and CT measurements.
Conclusions: While lung function and CT measures of the lung structure were similar, dyspnea is reported more 
frequently by Hispanic than matched-NHW smokers.
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Abbreviations: chronic obstructive pulmonary disease, COPD; non-Hispanic white, NHW; computed tomography, CT; branching generation 
number, BGN; odds ratio, OR; confidence interval, CI; Pittsburgh Lung Screening Study, PLuSS; forced expiratory volume in 1 second, 
FEV1; forced vital capacity, FVC; forced expiratory flow between 25% and 75% of FVC, FEF25%-75%; percent of low attenuation areas 
below-950 Hounsfield units, %LAA-950; right upper lobe apical bronchus, RB1; right lower lobe basal posterior bronchus, RB10; total 
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Introduction
In 2015, 36.5 million people in the United States 
were current smokers.1 Before meeting criteria for 
chronic obstructive pulmonary disease (COPD), 
smokers manifest respiratory symptoms and have 
emphysematous destruction of lung parenchyma and 
airway disease that can be measured on computed 
tomography (CT) similar to those with established 
disease.2,3 Much of what we know about these clinical 
and radiographic manifestations in smokers comes 
from large studies that have included mostly non-
Hispanic white populations.2-5 Although Hispanics are 
the largest and fastest growing minority in the United 
States,6 now numbering 56.5 million people, and 
represent the majority population in certain areas of 
the United States, they are understudied. Interestingly, 
recent investigations suggest that despite comparable 
smoking habits and occupational exposures, Hispanic 
smokers (i.e., Hispanics from New Mexico and Mexican-
Americans) have a slower rate of lung function decline 
and a lower risk for COPD than their non-Hispanic 
white (NHW) counterparts.7,8,9
These racial-ethnic differences in disease risk may be 
due to differential responses of the airways and lung 
parenchyma to tobacco injury. Detailed examination 
of lung structure and extra-pulmonary tissues would 
be necessary to show these differences. Prior studies 
did not find racial-ethnic differences in CT measures 
of emphysema and airway morphology. However, those 
studies were limited by their assessment only of one 
quantitative imaging phenotype (emphysema or airway 
disease) on cardiac CTs.10,11 Other CT phenotypes 
such as pulmonary vascular pruning and measures of 
extra-pulmonary tissues such as muscle and fat mass 
are now available, thereby expanding our ability to 
assess smoking-related diseases.12-15 In the present 
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study, we aimed to explore pulmonary symptoms, lung 
function, and lung structure as well as muscle and fat 
tissue mass in Hispanic and NHW smokers. We tested 
the hypothesis that Hispanics might be less susceptible 
to smoking-induced injury compared to NHWs and that 
could be associated with greater airway lumens, more 
parallel pathways, and less emphysema and vascular 
pruning.  To test this hypothesis, we used sex-, age-, 
and smoking exposure-matched Hispanic and non-
Hispanic whites from the Pittsburgh Lung Screening 
Study (PLuSS).16
Cohort 
Clinical and CT data at baseline from participants 
enrolled in PLuSS from January 2001 to April 2005 
were used.16 Inclusion criteria were the following: age 
50-79 years; body weight <400 pounds; no personal 
history of lung cancer; nonparticipation in concomitant 
lung cancer screening studies; no chest CT in the 
prior year; former or current cigarette smoker of at 
least one-half pack/day for 25 or more years; former 
smokers must have quit within 10 years prior to study 
enrollment. Symptoms were not part of the exclusion 
criteria.  
We used all self-identified Hispanic participants 
and matched them with non-Hispanic whites based 
on same sex, age (±2 years), and smoking exposure. 
Smoking exposure matching was based on the age 
when participants started smoking (±2 years) and quit 
smoking (±2 years) if applicable, the same current 
smoking status, and the same category of smoking 
intensity (cigarettes/day categories: 1-9; 10-19; 20-
29; 30-39; and 40 or more). This approach allowed 
us to explore potential differences in susceptibility 
to smoking-induced injury based on race-ethnicity. 
African-American individuals were not included in this 
study.  The institutional review board for the University 
of Pittsburgh approved PLuSS and its participants 
gave informed consent to participate in the study.16 
The informed consent was given to the participants in 
English only. 
Clinical and Functional Assessment
Demographics, smoking history, and pulmonary 
symptoms (non-productive cough, phlegm, wheeze, 
and dyspnea) were collected in standardized manner 
using a PLuSS designed questionnaire, which was 
Methods
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given to the participants in English only. Participants 
were asked, “Have you recently experienced any of 
the following symptoms?” The respiratory symptoms 
included “dry cough”, “cough that produces phlegm”, 
“wheezing”, and “shortness of breath” with binary yes/
no response options. The participant was considered to 
have a respiratory symptom if he/she answered “yes” 
to any of those options. Spirometry was performed 
and analyzed following the American Thoracic Society 
standards.17 We used the forced expiratory volume in 
one second (FEV1), forced vital capacity (FVC), FEV1/
FVC ratio, and forced expiratory flow between 25% and 
75% (FEF25-75%) of FVC and their predicted values 
in our analysis. The predicted values were derived from 
prediction equations for the U.S. population.18
CT Protocol
PLuSS participants were imaged using a single-
breath-hold, helical, low-dose CT protocol (40–60 mA; 
140 kVp) to obtain axial images. The images were 
reconstructed with a high spatial frequency (lung) 
algorithm at contiguous 2.5-mm intervals.16
Emphysema and Airway Assessment
A trained analyst analyzed the CTs using the Chest 
Imaging Platform.19 Because PLuSS CTs are low-
dose, images were first smoothed using a median filter 
allowing decreasing noise and increasing densitometric 
measurements accuracy. Emphysema-like tissue was 
defined as percent of low attenuation areas below -950 
Hounsfield units (%LAA-950).20 Measures of airway 
morphology were taken using an anatomic approach 
at the 3rd and 4th generation level of the right upper 
lobe apical bronchus (RB1) and right lower lobe basal 
posterior bronchus (RB10). The first RB1 and RB10 
segment within the lobe was considered the third 
generation.21,22 RB1 and R10 were chosen as they run 
orthogonal to the axial plane making it possible to take 
more accurate measurements. The analyst identified 
the target bronchial segment orthogonal to the axial 
image and placed a point at the center of the lumen to 
segment the airway and obtain the measurements. Two 
sets of bronchial measurements were obtained in the 
middle portion of each segment. These measurements 
included lumen area and wall area percentage (wall 
area/wall area + lumen area .100).23 The ratio of the 
area of the daughter inner lumen to parent inner 
lumen was also computed and used to estimate the 
branching generation number (BGN) to reach a 
<2mm-lumen-diameter airway –the site of airflow 
obstruction in smokers as described previously.24 
The BGN is an estimation of how many branches (i.e., 
parallel pathways) there are between the proximal 
airways and a given distal airway size where greater 
values indicate greater number of parallel pathways. 
For this estimation, it is assumed that the bronchial 
tree is a dichotomous branching system where each 
generation had 2n parallel pathways (where “n” is 
the generation). If the projected BGN ranged from 6 
to 8 (i.e., 3 to 5 generations past the 3rd generation), 
then a participant would theoretically have between 
64 and 256 parallel pathways of similar size (for a 6th 
generation 2mm-airway 26=64 parallel paths, for an 
8th generation 2mm-airway 28=256 parallel paths).
Pulmonary Vascular Assessment
We used a 3-dimensional volumetric model to assess 
the pulmonary vascular morphology on non-contrast 
CT scans.15 This methodology allows extracting the 
vascular tree and quantifying the total blood vessel 
volume (TBV). This assessment provides the aggregate 
pulmonary vessel volume including artery and veins 
in all vessels less than 10mm2 in cross section (BV10) 
for the whole-lung, a modified metric for low-dose CT 
scans from prior work.15 To account for differences in 
lung size across participants, the BV10 is expressed as 
a function of TBV. A lower BV10/TBV ratio indicates a 
greater vessel pruning.
Muscle and Fat Assessment
Measures of muscle and fat tissues were taken on 
chest CT scan. The methodology and reproducibility 
of these measures have been previously reported.12-14 
We measured the pectoralis muscle area (PMA),12 
subcutaneous adipose tissue (SAT)13 area anterior 
to the pectoralis muscles, and visceral adipose tissue 
(VAT).14 The first 2 measurements are obtained from 
a single-axial slice immediately above the aortic arch 
and the latter is taken from a single-axial slice at the 
inferior edge of the transverse process of the first 
lumbar vertebrae. The aggregate area (cm2) of the 4 
pectoralis muscles and the 2 sides of SAT measurement 
as well as VAT total area were used for analysis. 
Statistical Analysis
Data are presented as frequency (%) or mean ± 
standard deviation (SD). Differences between 
populations were tested using student t-tests or chi-
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than their NHW counterparts. The increased odds 
of dyspnea for Hispanics persisted after adjustment 
for both spirometrically defined COPD and history 
of asthma (odds ratio[OR]=2.96; 95%, confidence 
interval [CI] 1.09-8.04). No significant differences 
were observed in other respiratory symptoms, FEV1, 
FVC, and FEV1/FVC.
CT Measurements 
No significant differences were found in any of the 
CT measurements (airway morphology, BGN, %LAA-
950, vascular morphology, PMA, SAT, and VAT) 
between Hispanics and NHWs (Table 2). The lack of 
racial-ethnic differences in airway lumen size was also 
observed when RB1 airway lumen area was adjusted for 
body surface area (BSA) as lumen area/BSA or height 
as lumen area/m2 (P >0.73 for both comparisons).
Thirty-nine out of 3642 participants who underwent 
CT scanning at baseline were Hispanics. The Hispanic 
participants were successfully matched for age, sex, 
and smoking history with 39 NHWs. The participants’ 
characteristics are shown in Table 1. Hispanic smokers 
had almost 2 times higher proportion of dyspnea 
Results
squared tests for continuous and categorical variables, 
respectively.  Logistic regression was performed to 
assess the relationship between a binary variable (i.e., 
presence of a respiratory symptom) and race-ethnicity. 
A P value less than 0.05 was considered of statistical 
significance. The analysis was performed with SAS 9.4 
(SAS institute, Cary, North Carolina) software package.
In this study, we performed an evaluation of 
respiratory symptoms and lung function as well as a 
comprehensive analysis of CT lung measurements 
and extra-pulmonary tissues from Hispanic and 
matched-NHW smokers. We found that Hispanics 
reported almost two-fold more dyspnea than NHWs. 
However, racial-ethnic differences in lung function, 
lung structure, and extra-pulmonary tissues were not 
observed. 
Smokers with and without COPD frequently report 
dyspnea. In our study, despite Hispanics and NHWs 
having similar CT-based lung structural damage and 
lung function, the minority group reported almost 
twice more often dyspnea. An explanation for this 
difference is that compared to NHWs with similar 
lung function, Hispanic smokers may have a lower 
perception threshold for this symptom. We have 
previously reported that New Mexican Hispanic 
smokers (versus NHWs) more often reported 
dyspnea in univariate analysis, and that they also 
experience a worse perception of their health-
related quality of life as measured by the St George’s 
Respiratory Questionnaire that includes questions 
about this symptom.25 Additionally, the feeling of 
“breathlessness” is described with both upper airway 
(e.g., tight throat) and lower airway word descriptors 
(e.g., sore lung) by Hispanics compared to just the 
lower airway word descriptors used by NHWs26 
Discussion
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supporting the racial-ethnic difference we observed. 
But an additional prior study in Mexican-Americans 
did not find differences in this symptom compared to 
NHWs.7 That study, however, included never smokers, 
which may have obscured the differences we observed 
in heavy smokers. A potential implication of current 
and prior findings is that these racial-ethnic differences 
in dyspnea perception might be considered when 
evaluating a Hispanic smoker in routine clinical visits. 
We also performed a comprehensive chest CT 
assessment to explore potential Hispanic-NHW 
structural differences in response to tobacco injury. 
We were surprised by both the remarkable similarity 
in some of the imaging estimates (e.g., airway lumen 
area, vascular pruning) and the consistent lack of 
differences in all structures/tissues evaluated between 
the 2 populations. One possible explanation of our 
findings is that racial-ethnic differences in tobacco-
induced injury do not translate into morphologic 
responses of lung structure. Other studies have failed 
to find racial-ethnic differences in emphysema and 
airway disease10,11 and here the lack of difference was 
expanded to vascular pruning and extra-pulmonary 
manifestations of COPD such as muscle and fat mass. 
Although some may feel that our sample size might 
obscure potential differences, the close estimates for 
some CT measurements between the populations 
make this less likely. However, these findings do not 
exclude the possibility that differences in smoking-
induced changes of lung structures might exist 
between other Hispanic subgroups and NHWs. For 
example, a cohort of Hispanics from New Mexico with 
greater Native American ancestry than that of NHWs 
had lower risk of COPD.8 This suggests that lung 
structure might differ by ancestry rather than ethnicity 
as a broad category. Additionally, differences in other 
structures that were not measured in our study such 
as small airways may exist.27 Furthermore, differences 
in inflammatory response to smoking injury, and/or 
protease-anti-protease misbalance may explain racial-
ethnic differences in COPD risk previously observed. 
Further investigations including imaging, genetics, 
and environmental assessments are warranted to 
elucidate the determinants of COPD risk and disease 
progression in all U.S. racial-ethnic groups. 
Several limitations should be noted. First, this is a 
convenience, small-sized sample of heavy smokers 
and caution should be exercised to extrapolate these 
findings to the larger population of smokers or 
Hispanics as a whole. We do not have information 
on ancestry (European, Native American, African), 
nativity (U.S. born versus non-U.S. born), and origin 
(e.g., Mexican-American, Puerto Ricans) of these 
participants, thus those important characteristics 
that are associated with observed differences in lung 
function decline and COPD risk could not be factored 
into our analysis.8,28 While this lack of information 
limits the external validity of our findings, it might 
encourage further exploration of smoking-induced 
changes in lung structure and COPD susceptibility 
based on race-ethnicity using more refined methods 
to characterize populations such as ancestry. The 
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assessment of respiratory symptoms was based on 
their presence or absence only and smoking intensity 
was collected as category of cigarettes/day. Finally, 
COPD measures on expiratory images such as air 
trapping were not available. Despite this limitation, we 
were able to expand prior imaging characterization in 
Hispanics by analyzing the pulmonary vasculature and 
extra-pulmonary tissues. Low-dose CT scans imposed 
challenges for lung densitometric analysis due to a 
reduced signal/noise ratio, but smoothing the PLuSS 
images allowed us to obtain emphysema-like tissue 
measurements that were in the range of those reported 
from studies using high-dose CT scans. 
In summary, Hispanic heavy smokers report dyspnea 
2 times more often than their age-, sex- and smoking 
exposure-matched NHW counterparts. It appears that 
there are no differences in CT measures of COPD 
between Hispanic and NHW smokers. Further research 
including imaging, genetics, and environmental 
exposure assessments are needed to ascertain the 
determinants of COPD and disease progression in all 
U.S. racial-ethnic groups.
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